← Leaderboards
James C Yang
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorT-LymphocyteMalignant NeoplasmsCellsProteinsImmuneT-Cell ReceptorAntigensReagentMutationRenal CarcinomaImmune ResponseMelanomaMutateT Cell TherapyReceptorNeoantigensAntigen TargetingCloningImmunotherapyLymphocyteNon-Small-Cell Lung CarcinomaEngineeringNormal Tissue Morphology
Grant awards (62)
Studying Immune Recognition of Epithelial Cancers Using Organoids$1,199,392
ZIA · FY2025 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$899,545
ZIA · FY2025 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing Non-Small Cell Lung Cancer$599,696
ZIA · FY2025 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$299,849
ZIA · FY2025 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$1,050,974
ZIA · FY2024 · CA · contact PI
Studying Immune Recognition of Epithelial Cancers Using Organoids$788,231
ZIA · FY2024 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing Non-Small Cell Lung Cancer$525,487
ZIA · FY2024 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$262,744
ZIA · FY2024 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$928,747
ZIA · FY2023 · CA · contact PI
Studying Immune Recognition of Epithelial Cancers Using Organoids$696,560
ZIA · FY2023 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$464,374
ZIA · FY2023 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$232,187
ZIA · FY2023 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$1,218,104
ZIA · FY2022 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$406,034
ZIA · FY2022 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$406,033
ZIA · FY2022 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$1,154,442
ZIA · FY2021 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$384,815
ZIA · FY2021 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$384,815
ZIA · FY2021 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$1,089,922
ZIA · FY2020 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$363,308
ZIA · FY2020 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$363,308
ZIA · FY2020 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$914,613
ZIA · FY2019 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$304,871
ZIA · FY2019 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$304,871
ZIA · FY2019 · CA · contact PI
Identification and use of T-cell receptors recognizing common tumor mutations$627,186
ZIA · FY2018 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$376,312
ZIA · FY2018 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$250,875
ZIA · FY2018 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$943,503
ZIA · FY2017 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$404,359
ZIA · FY2017 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$1,064,132
ZIA · FY2016 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$456,056
ZIA · FY2016 · CA · contact PI
Laboratory and Clinical studies on T-cells recognizing NSCLC$699,349
ZIA · FY2015 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$699,349
ZIA · FY2015 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$1,486,778
ZIA · FY2014 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$1,163,889
ZIA · FY2013 · CA · contact PI
Characterizing a novel tumor recognition mechanism$129,321
ZIA · FY2013 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$1,110,635
ZIA · FY2012 · CA · contact PI
Characterizing a novel tumor recognition mechanism$138,829
ZIA · FY2012 · CA · contact PI
Identification of Molecular Factors Associated with Response to Interleukin-2$138,829
ZIA · FY2012 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$879,534
ZIA · FY2011 · CA · contact PI
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells$125,648
ZIA · FY2011 · CA · contact PI
Identification of Molecular Factors Associated with Response to Interleukin-2$125,648
ZIA · FY2011 · CA · contact PI
Characterizing a novel tumor recognition mechanism$125,648
ZIA · FY2011 · CA · contact PI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors$518,832
ZIA · FY2010 · CA · contact PI
Characterizing a novel tumor recognition mechanism$259,416
ZIA · FY2010 · CA · contact PI
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells$259,416
ZIA · FY2010 · CA · contact PI
Identification of Molecular Factors Associated with Response to Interleukin-2$259,416
ZIA · FY2010 · CA · contact PI
Characterizing a novel tumor recognition mechanism$877,504
ZIA · FY2009 · CA · contact PI
Identification of Molecular Factors Associated with Response to Interleukin-2$292,502
ZIA · FY2009 · CA · contact PI
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells$292,502
ZIA · FY2009 · CA · contact PI
Defining the T-cell Response to Human Renal Cancer$594,220
Z01 · FY2008 · CA · contact PI
Characterizing a novel tumor recognition mechanism$594,220
Z01 · FY2008 · CA · contact PI
Characterizing a novel tumor recognition mechanism$1,252,404
Z01 · FY2007 · CA · contact PI
Defining the T-cell Response to Human Renal Cancer$1,252,404
Z01 · FY2007 · CA · contact PI
Defining the T-cell Response to Human Renal Cancer$0
Z01 · FY2006 · SC · contact PI
Generation of T-cell Responses by Dendritic Cell Present$0
Z01 · FY2006 · BC · contact PI
Generation of T-cell responses by dendritic cell present$0
Z01 · FY2005 · BC
Defining the T-cell response to human renal cancer$0
Z01 · FY2005 · SC
Defining the T-cell response to human renal cancer$0
Z01 · FY2004 · SC
Defining the T-cell response to human renal cancer$0
Z01 · FY2003 · SC
Study of Interleukin-2 Based Immunotherapy$0
Z01 · FY2001 · SC
Study of Interleukin-2 Based Immunotherapy$0
Z01 · FY2000 · SC